Related Posts
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
- admin
- August 24, 2026
- 4 min read
- 0
Insider Brief Insilico Medicine launched the Open Drug Discovery and Development Consortium, or O3DC, to improve transparency around how computational drug-discovery benchmarks are evaluated and used. O3DC’s Benchmark Index catalogs hundreds of benchmarks across 10 categories while documenting known biases, limitations and criticisms that may affect how performance results are interpreted. The free, community-curated initiative […]
Silver Ferns slam Netball NZ’s lack of ANZ Premiership clarity
- admin
- June 29, 2026
- 1 min read
- 0
Amelia Walmsley, Mila Reuelu-Buchanan, Martina Salmon and Maia Wilson have spoken out.
10 Nordic-Based AI Scale-Ups You Need to Know in 2026
- admin
- August 27, 2026
- 6 min read
- 0
The Nordics have built a reputation for pairing deep technical rigor with a genuine focus on solving specific, high-stakes problems, and this list bears that out. Sweden contributes the largest share, with entries spanning video analytics, data observability, and driving risk insights, while Denmark brings clinical AI for radiology and elder care, and Finland and […]
WhyQ spent a decade pivoting. It might have finally found the model that works.
- admin
- June 30, 2026
- 5 min read
- 0
“The more we scaled, the more we burned” It’s been a long road for WhyQ. In 2016, the company was built around a straightforward idea: make hawker food more accessible to busy office workers in the CBD. After years of pivots, a pandemic-era detour into residential deliveries, and the hard lessons that came with it, […]